Norsk Patenttidende nr 07/05 - Patentstyret
Norsk Patenttidende nr 07/05 - Patentstyret
Norsk Patenttidende nr 07/05 - Patentstyret
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
(51) Klasse : A61K 031/546<br />
A61K 047/10<br />
A61P 031/04<br />
(21) Søknads<strong>nr</strong> : 20042271<br />
(22) Inndag : 2004.06.01<br />
(41) Allm.tilgj : 2004.<strong>07</strong>.22<br />
(30) Prioritet : 2001.11.30, US, 338536<br />
2002.<strong>07</strong>.26, US, 398932<br />
(86) Int.inndag : 2002.11.13<br />
(86) Int.søknads<strong>nr</strong> : PCT/IB02/04743<br />
(24) Løpedag 2002.11.13<br />
(71) Søker<br />
Pfizer Products Inc , Eastern Point Road, CT06340<br />
GROTON, US<br />
(74) Fullmektig<br />
Bryn Aarflot AS , Postboks 449 Sentrum, 0104 OSLO, NO<br />
(72) Oppfinner<br />
Brian Scott Bronk, c/o Pfizer Global Research and<br />
Development, Eastern Point Road, GROTON, CT06340, US<br />
Roger Nelson Kimball, Pfizer Global Research and<br />
Development, Eastern Point Road, GROTON, CT06340, US<br />
Renuka Devi Reddy, Pfizer Global Research and<br />
Development, Eastern Point Road, GROTON, CT06340, US<br />
Evgenyi Yur'evich Shalaev, c/o Pfizer Global Research and<br />
Development, Eastern Point Road, GROTON, CT06340, US<br />
Simon Edvard Blanchflower, c/o Pfizer Global Research and<br />
Development, Eastern Point Road, GROTON, CT06340, US<br />
(54) Benevnelse<br />
Formuleringer som inneholder en cefalosporinforbindelse og<br />
deres anvendelse for behandling av bakterielle infeksjoner i<br />
katter og hunder<br />
(51) Klasse : A61K 031/546<br />
A61K 009/00<br />
(21) Søknads<strong>nr</strong> : 20042620<br />
(22) Inndag : 2004.06.22<br />
(41) Allm.tilgj : 2004.06.22<br />
(30) Prioritet : 2001.11.23, EP, 01500277<br />
(86) Int.inndag : 2002.11.21<br />
(86) Int.søknads<strong>nr</strong> : PCT/EP02/13150<br />
(24) Løpedag 2002.11.21<br />
(71) Søker<br />
Glaxo Group Ltd , Glaxo Wellcome House, Berkeley<br />
Avenue, UB60NN GREENFORD, MIDDLESEX, GB<br />
(74) Fullmektig<br />
Bryn Aarflot AS , Postboks 449 Sentrum, 0104 OSLO, NO<br />
(72) Oppfinner<br />
Matilde Ibanez Fernandez, c/o GlaxoSmithKline, Severo<br />
Ochoa 2, TRES CANTOS, 28760, ES<br />
Emilio Sanz Garriz, c/o GlaxoSmithKline, Severo Ochoa 2,<br />
TRES CANTOS, 28760, ES<br />
(54) Benevnelse<br />
Belagte partikulære cefuroxim axetil-blandinger<br />
allment tilgjengelige patentsøknader (A) 20<strong>05</strong>.02.14 - <strong>nr</strong> <strong>07</strong>/<strong>05</strong><br />
34<br />
(51) Klasse : A61K 031/337<br />
A61K 031/4745<br />
A61K 031/7068<br />
(21) Søknads<strong>nr</strong> : 20042609<br />
(22) Inndag : 2004.06.22<br />
(41) Allm.tilgj : 2004.06.22<br />
(30) Prioritet : 2001.11.23, EP, 01127401<br />
2001.12.19, EP, 01130245<br />
2002.03.12, EP, 020<strong>05</strong>298<br />
(86) Int.inndag : 2002.11.18<br />
(86) Int.søknads<strong>nr</strong> : PCT/EP02/12911<br />
(24) Løpedag 2002.11.18<br />
(71) Søker<br />
Chugai Seiyaku KK , 5-1, Ukima 5-chome, Kita-ku, 115-8543<br />
TOKYO, JP<br />
(74) Fullmektig<br />
Tandbergs Patentkontor AS , Postboks 7085 Majorstua,<br />
0306 OSLO, NO<br />
(72) Oppfinner<br />
Hideo Ishitsuka, 5-15-2<strong>07</strong> Kaigan 2-chome, Minato-ku,<br />
TOKYO, 1<strong>05</strong>-0022, JP<br />
Hisafumi Okabe, c/o Chugai Seiyaku K K , 200, Kajiwara,<br />
KAMAKURA-SHI, KANAGAWA, 247-8530, JP<br />
Nobuo Shimma, c/o Chugai Seiyaku KK , 200 Kajiwara,<br />
KAMAKURA-SHI, KANAGAWA, 247-8530, JP<br />
Takuo Tsukuda, c/o Chugai Seiyaku K K , 200, Kajiwara,<br />
KAMAKURA-SHI, KANAGAWA, 247-8530, JP<br />
Isao Umeda, c/o Chugai Seiyaku K K , 200, Kajiwara,<br />
KAMAKURA-SHI, KANAGAWA, 247-8530, JP<br />
(54) Benevnelse<br />
Fremgangsmåte for identifisering av tumormålrettede<br />
enzymer<br />
(51) Klasse : A61K 045/06<br />
A61P 029/00<br />
A61P 017/06<br />
A61P 035/04<br />
(21) Søknads<strong>nr</strong> : 20041618<br />
(22) Inndag : 2004.04.21<br />
(41) Allm.tilgj : 2004.<strong>07</strong>.22<br />
(30) Prioritet : 2001.10.23, JP, 324435/01<br />
(86) Int.inndag : 2002.03.18<br />
(86) Int.søknads<strong>nr</strong> : PCT/JP02/02552<br />
(24) Løpedag 2002.03.18<br />
(71) Søker<br />
Ono Pharmaceutical Co Ltd , 1-5, Doshomachi 2-chome,<br />
Chuo-ku, 541-8526 OSAKA-SHI, OSAKA, JP<br />
(74) Fullmektig<br />
JK Thorsens Patentbureau AS , Postboks 9276 Grønland,<br />
0134 OSLO, NO<br />
(72) Oppfinner<br />
Shiro Shibayama, c/o Minase Research Inst., Ono Pharma<br />
Co Ltd, 1-1, Sakurai 3-chome, Shimamoto, MISHIMA-GUN,<br />
OSAKA, 618-8585, JP<br />
Yoshikazu Takaoka, c/o Minase Research Inst., Ono<br />
Pharma Co Ltd, 1-1, Sakurai 3-chome, Shimamoto,<br />
MISHIMA-GUN, OSAKA, 618-8585, JP<br />
Haruo Imawaka, c/o Minase Research Institute, Ono<br />
Pharmaceutical Co Ltd, 1-1, Sakurai 3-chome, Shimamotocho,<br />
MISHIMA-GUN, OSAKA, 618-8585, JP<br />
(54) Benevnelse<br />
Legemidler omfattende en kombinasjon av<br />
triazaspiro[5,5]undekanderivat med cytokrom P450 isozyn<br />
3A4 inhibitor og/eller P-glykoproeininhibitor